Related Experiment Video
Updated: Aug 22, 2025

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis
Samuel T Savitz1, Thomas Leong2, Sue Hee Sung2
1Division of Research, Kaiser Permanente Northern California, Oakland, CA; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN; Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN.
Developing accurate prediction models for 30-day outcomes after transcatheter aortic valve replacement (TAVR) remains challenging, even with extensive data. Further research is needed to improve personalized patient care and monitoring strategies post-TAVR.
Area of Science:
- Cardiology
- Medical Informatics
- Health Services Research
Background:
- Transcatheter aortic valve replacement (TAVR) for aortic stenosis has expanded, but accurately predicting patient outcomes is still a challenge.
- Existing risk stratification methods may not fully capture the complexity of post-TAVR outcomes.
- There is a need for improved prediction models for both clinical and patient-centered outcomes.
Purpose of the Study:
- To develop and evaluate prediction models for 30-day clinical and patient-centered outcomes following TAVR.
- To assess the predictive performance of models using integrated data sources.
- To identify key predictors for short-term outcomes after TAVR in a large, diverse population.
Main Methods:
- A cohort of 1,565 adult patients undergoing TAVR from 2013-2019 was identified.
- Gradient boosting machines were used to develop prediction models incorporating data from the TVT Registry and electronic health records.
- Model performance was evaluated using area under the curve (AUC) for discrimination and calibration plots.
Main Results:
- The risk of adverse 30-day outcomes varied, from 1.3% for heart failure hospitalizations to 15.3% for all-cause emergency department visits.
- Model discrimination was moderate for death (AUC 0.60) and quality of life (AUC 0.62), but better for heart failure-related ED visits (AUC 0.76).
- The STS risk score only predicted death and all-cause hospitalization; older age predicted HF-related ED visits; race/ethnicity was not significant.
Conclusions:
- Predicting short-term clinical and patient-centered outcomes after TAVR remains difficult despite comprehensive data.
- Current models show moderate predictive power, highlighting the need for novel predictors.
- Further research is essential to enhance personalized decision-making and monitoring strategies for TAVR patients.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Aneurysm IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
Mitral Stenosis IV: Nursing Management

